The company has not filed an annual or quarterly report since its Q1 FY2020 10-Q, filed May 8, 2020. Its latest SEC filing is a SC 13G/A from Feb 14, 2022.
10-Q for Q1 FY2020, filed May 8, 2020
The sections below describe the company as of the FY2019 annual report.
Seeks to combine with a business, particularly in healthcare, life sciences and medical technology, through a merger or similar transaction.
10-K for FY2019, filed Mar 6, 2020
No revenue was reported.
10-K for FY2019, filed Mar 6, 2020
10-Q for Q1 FY2020, filed May 8, 2020
−$3.3MView ↗
8-K, filed Jun 29, 2020
The shareholders approved the Business Combination Agreement, dated March 17, 2020 (as amended), by and among ARYA, Immatics, TopCo…View ↗
8-K, filed Mar 17, 2020
On March 17, 2020, ARYA Sciences Acquisition Corp., a Cayman Islands exempted company (“ARYA”), entered into a Business Combination…View ↗
Loading...
